{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T21:11:07Z","timestamp":1789852267126,"version":"4.0.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Sch\u00e9ma directeur Paludisme, Etat Major des Arm\u00e9es Fran\u00e7aises","award":["grant LR 607a"],"award-info":[{"award-number":["grant LR 607a"]}]},{"DOI":"10.13039\/501100005902","name":"D\u00e9l\u00e9gation G\u00e9n\u00e9rale pour l\u2019Armement","doi-asserted-by":"crossref","award":["grant PDH-2-NRBC-4-B1-402"],"award-info":[{"award-number":["grant PDH-2-NRBC-4-B1-402"]}],"id":[{"id":"10.13039\/501100005902","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003388","name":"Minist\u00e8re des Affaires \u00c9trang\u00e8res","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003388","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12936-016-1379-2","type":"journal-article","created":{"date-parts":[[2016,7,7]],"date-time":"2016-07-07T07:34:53Z","timestamp":1467876893000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Prevalence of anti-malarial resistance genes in Dakar, Senegal from 2013 to 2014"],"prefix":"10.1186","volume":"15","author":[{"given":"Agathe","family":"Boussaroque","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9caye","family":"Fall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marylin","family":"Madamet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalifa Ababacar","family":"Wade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansour","family":"Fall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aminata","family":"Nakoulima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khadidiatou Ba","family":"Fall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Dionne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Benoit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bakary","family":"Diatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaya","family":"Diem\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boubacar","family":"Wade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Pradines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,7]]},"reference":[{"key":"1379_CR1","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0140-6736(06)68264-0","volume":"367","author":"B Ciss\u00e9","year":"2006","unstructured":"Ciss\u00e9 B, Sokhna C, Boulanger D, Milet J, Ba EH, Richardson K, et al. Seasonal intermittent preventive treatment with artesunate and sulfadoxine\u2013pyrimethamine for prevention of malaria in Senegalese children: a randomized, placebo-controlled, double-blind trial. Lancet. 2006;367:659\u201367.","journal-title":"Lancet"},{"key":"1379_CR2","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1371\/journal.pone.0001471","volume":"3","author":"C Sokhna","year":"2008","unstructured":"Sokhna C, Ciss\u00e9 B, Ba EH, Milligan P, Hallett R, Sutherland C, et al. A trial of the efficacy, safety and impact on drug resistance of four drug regimens for seasonal intermittent preventive treatment for malaria in Senegalese children. PLoS One. 2008;3:1471.","journal-title":"PLoS One"},{"key":"1379_CR3","doi-asserted-by":"crossref","first-page":"7164","DOI":"10.1371\/journal.pone.0007164","volume":"4","author":"B Ciss\u00e9","year":"2009","unstructured":"Ciss\u00e9 B, Cairns M, Faye E, NDiaye O, Faye B, Cames C, et al. Randomized trial of piperaquine with sulfadoxine\u2013pyrimethamine or dihydroartemisinin for malaria intermittent preventive treatment in children. PLoS One. 2009;4:7164.","journal-title":"PLoS One"},{"key":"1379_CR4","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S1097-2765(05)00077-8","volume":"6","author":"DA Fidock","year":"2000","unstructured":"Fidock DA, Nomura T, Talley AK, Cooper RA, Dzekunov SM, Ferdig MT, et al. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol Cell. 2000;6:861\u201371.","journal-title":"Mol Cell"},{"key":"1379_CR5","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0140-6736(04)16767-6","volume":"364","author":"RN Price","year":"2004","unstructured":"Price RN, Uhlemann AC, Brockman A, McReady R, Ashley E, Phaipun L, et al. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet. 2004;364:438\u201347.","journal-title":"Lancet"},{"key":"1379_CR6","doi-asserted-by":"crossref","first-page":"935","DOI":"10.2174\/138945006778019372","volume":"7","author":"M Henry","year":"2006","unstructured":"Henry M, Alibert S, Orlandi-Pradines E, Bogreau H, Fusai T, Rogier C, et al. Chloroquine resistance reversal agents as promising antimalarial drugs. Curr Drug Targets. 2006;7:935\u201348.","journal-title":"Curr Drug Targets"},{"key":"1379_CR7","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2174\/156802608783955593","volume":"8","author":"M Henry","year":"2008","unstructured":"Henry M, Alibert S, Rogier C, Barbe J, Pradines B. Inhibition of efflux of quinolines as new therapeutic strategy in malaria. Curr Top Med Chem. 2008;8:563\u201378.","journal-title":"Curr Top Med Chem"},{"key":"1379_CR8","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0166-6851(89)90173-4","volume":"36","author":"JW Zolg","year":"1989","unstructured":"Zolg JW, Plitt JR, Chen GX, Palmer S. Point mutations in the dihydrofolate reductase-thymidylate synthase gene as the molecular basis for pyrimethamine resistance in Plasmodium falciparum. Mol Biochem Parasitol. 1989;36:253\u201362.","journal-title":"Mol Biochem Parasitol"},{"key":"1379_CR9","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1046\/j.1365-2958.1997.2821646.x","volume":"23","author":"P Wang","year":"1997","unstructured":"Wang P, Read M, Sims PF, Hyde JE. Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization. Mol Microbiol. 1997;23:979\u201386.","journal-title":"Mol Microbiol"},{"key":"1379_CR10","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.meegid.2003.08.002","volume":"3","author":"H Tinto","year":"2003","unstructured":"Tinto H, Ou\u00e9draogo JB, Erhart A, van Overmeir C, Dujardin JC, van Marck E, et al. Relationship between the Pfcrt T76 and the Pfmdr-1 Y86 mutations in Plasmodium falciparum and in vitro\/in vivo chloroquine resistance in Burkina Faso, West Africa. Infect Genet Evol. 2003;3:287\u201392.","journal-title":"Infect Genet Evol"},{"key":"1379_CR11","doi-asserted-by":"crossref","first-page":"667","DOI":"10.4269\/ajtmh.2002.66.667","volume":"66","author":"LK Basco","year":"2002","unstructured":"Basco LK, Ringwald P. Molecular epidemiology of malaria in Cameroon.X. Evaluation of Pfmdr1 mutations as genetic markers for resistance to amino alcohols and artemisinin derivatives. Am J Trop Med Hyg. 2002;66:667\u201371.","journal-title":"Am J Trop Med Hyg"},{"key":"1379_CR12","doi-asserted-by":"crossref","first-page":"431","DOI":"10.4269\/ajtmh.2007.77.431","volume":"77","author":"P Parola","year":"2007","unstructured":"Parola P, Pradines B, Simon F, Carlotti MP, Minodier P, Ranjeva MP, et al. Antimalarial drug susceptibility and point mutations associated with resistance in 248 Plasmodium falciparum isolates imported from Comoros to Marseille. Am J Trop Med Hyg. 2007;77:431\u20137.","journal-title":"Am J Trop Med Hyg"},{"key":"1379_CR13","unstructured":"Programme national de lutte contre le paludisme. Bulletin \u00e9pid\u00e9miologique annuel du paludisme au S\u00e9n\u00e9gal. 2015. ( www.pnlp.sn\/telechargements\/Rapports\/BULLETIN-EPIDEMIOLOGIQUE-ANNUEL-2014-DU-PALUDISME-AU-SENEGAL.pdf )."},{"key":"1379_CR14","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1056\/NEJM200101253440403","volume":"344","author":"A Djimd\u00e9","year":"2001","unstructured":"Djimd\u00e9 A, Doumbo OK, Cortese JF, Kayentao K, Doumbo S, Diourt\u00e9 Y, et al. A molecular marker for chloroquine-resistant falciparum malaria. N Engl J Med. 2001;344:257\u201363.","journal-title":"N Engl J Med"},{"key":"1379_CR15","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/jac\/42.3.333","volume":"42","author":"B Pradines","year":"1998","unstructured":"Pradines B, Tall A, Parzy D, Spiegel A, Fusai T, Hienne R, et al. In vitro activity of pyronaridine and amodiaquine against African isolates (Senegal) of Plasmodium falciparum in comparison with standard antimalarial agents. J Antimicrob Chemother. 1998;42:333\u20139.","journal-title":"J Antimicrob Chemother"},{"key":"1379_CR16","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1093\/jac\/dkl117","volume":"57","author":"B Pradines","year":"2006","unstructured":"Pradines B, Tall A, Ramiandrasoa F, Spiegel A, Sokhna C, Fusai T, et al. In vitro activity of iron-binding compounds against Senegalese isolates of Plasmodium falciparum. J Antimicrob Chemother. 2006;57:1093\u20139.","journal-title":"J Antimicrob Chemother"},{"key":"1379_CR17","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1046\/j.1365-3156.2002.00848.x","volume":"7","author":"B Pradines","year":"2002","unstructured":"Pradines B, Tall A, Rogier C, Spiegel A, Mosnier J, Marrama L, et al. In vitro activities of ferrochloroquine against 55 Senegalese isolates of Plasmodium falciparum in comparison with those of standard antimalarial drugs. Trop Med Int Health. 2002;7:265\u201370.","journal-title":"Trop Med Int Health"},{"key":"1379_CR18","doi-asserted-by":"crossref","first-page":"474","DOI":"10.4269\/ajtmh.2002.66.474","volume":"66","author":"SM Thomas","year":"2002","unstructured":"Thomas SM, Ndir O, Dieng T, Mboup S, Wypij D, Maguire JH, et al. In vitro chloroquine susceptibility and PCR analysis of pfcrt and pfmdr1 polymorphisms in Plasmodium falciparum isolates from Senegal. Am J Trop Med Hyg. 2002;66:474\u201380.","journal-title":"Am J Trop Med Hyg"},{"key":"1379_CR19","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1007\/s00436-012-2994-7","volume":"111","author":"O Ly","year":"2012","unstructured":"Ly O, Gueye PE, Deme AB, Dieng T, Badiane AS, Ahouidi AD, et al. Evolution of the pfcrt T76 and pfmdr1 Y86 markers and chloroquine susceptibility 8\u00a0years after cessation of chloroquine use in Pikine, Senegal. Parasitol Res. 2012;111:1541\u20136.","journal-title":"Parasitol Res"},{"key":"1379_CR20","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s00436-005-1406-7","volume":"97","author":"O Sarr","year":"2005","unstructured":"Sarr O, Myrick A, Daily J, Diop BM, Dieng T, Ndir O, et al. In vivo and in vitro analysis of chloroquine resistance in Plasmodium falciparum isolates from Senegal. Parasitol Res. 2005;97:136\u201340.","journal-title":"Parasitol Res"},{"key":"1379_CR21","doi-asserted-by":"crossref","first-page":"146","DOI":"10.4269\/ajtmh.2006.75.146","volume":"75","author":"M Henry","year":"2006","unstructured":"Henry M, Diallo I, Bordes J, Ka S, Pradines B, Diatta B, et al. Urban malaria in Dakar, Senegal: chemosusceptibility and genetic diversity of Plasmodium falciparum isolates. Am J Trop Med Hyg. 2006;75:146\u201351.","journal-title":"Am J Trop Med Hyg"},{"key":"1379_CR22","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1186\/1475-2875-12-441","volume":"12","author":"D Tyne Van","year":"2013","unstructured":"Van Tyne D, Dieye B, Valim C, Daniels RF, Diogoye S\u00e8ne P, Lukens AK, et al. Changes in drug sensitivity and anti-malarial drug resistance mutations over time among Plasmodium falciparum parasites in Senegal. Malar J. 2013;12:441.","journal-title":"Malar J"},{"key":"1379_CR23","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1186\/1475-2875-10-310","volume":"10","author":"B Fall","year":"2011","unstructured":"Fall B, Diawara S, Sow K, Baret E, Diatta B, Fall KB, et al. Ex vivo susceptibility of Plasmodium isolates from Dakar, Senegal, to seven standard anti-malarial drugs. Malar J. 2011;10:310.","journal-title":"Malar J"},{"key":"1379_CR24","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/1475-2875-11-197","volume":"11","author":"N Wurtz","year":"2012","unstructured":"Wurtz N, Fall B, Pascual A, Diawara S, Sow K, Baret E, et al. Prevalence of molecular markers of Plasmodium falciparum drug resistance in Dakar, Senegal. Malar J. 2012;11:197.","journal-title":"Malar J"},{"key":"1379_CR25","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1475-2875-12-107","volume":"12","author":"B Fall","year":"2013","unstructured":"Fall B, Pascual A, Sarr FD, Wurtz N, Richard V, Baret E, et al. Plasmodium falciparum susceptibility to anti-malarial drugs in Dakar, Senegal, in 2010: an ex vivo and drug resistance molecular markers study. Malar J. 2013;12:107.","journal-title":"Malar J"},{"key":"1379_CR26","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12936-015-0589-3","volume":"14","author":"B Fall","year":"2015","unstructured":"Fall B, Camara C, Fall M, Nakoulima A, Dionne P, Diatta B, et al. Plasmodium falciparum susceptibility to standard and potential anti-malarial drugs in Dakar, Senegal, during the 2013\u20132014 malaria season. Malar J. 2015;14:60.","journal-title":"Malar J"},{"key":"1379_CR27","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3201\/eid2205.151321","volume":"22","author":"B Fall","year":"2016","unstructured":"Fall B, Madamet M, Camara C, Amalvict R, Fall M, Nakoulima A, et al. Emergence of Plasmodium falciparum in vitro resistance to monodesethylamodiaquine in Dakar, Senegal in 2014. Emerg Infect Dis. 2016;22:841\u20135.","journal-title":"Emerg Infect Dis"},{"key":"1379_CR28","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4269\/ajtmh.1999.60.105","volume":"60","author":"B Pradines","year":"1999","unstructured":"Pradines B, Mabika Mamfoumbi M, Parzy D, Owono Medang M, Lebeau C, Mourou Mbina JR, et al. In vitro susceptibility of African ioslates of Plasmodium falciparum from Gabon to pyronaridine. Am J Trop Med Hyg. 1999;60:105\u20138.","journal-title":"Am J Trop Med Hyg"},{"key":"1379_CR29","doi-asserted-by":"crossref","first-page":"7032","DOI":"10.1128\/AAC.03494-14","volume":"58","author":"N Wurtz","year":"2014","unstructured":"Wurtz N, Fall B, Pascual A, Fall M, Baret E, Camara C, et al. Role of Pfmdr1 in in vitro susceptibility to chloroquine, quinine, monodesethylamodiaquine, mefloquine, lumefantrine and dihydroartemisinin. Antimicrob Agents Chemother. 2014;58:7032\u201340.","journal-title":"Antimicrob Agents Chemother"},{"key":"1379_CR30","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.4269\/ajtmh.2010.10-0339","volume":"83","author":"M Mungthin","year":"2010","unstructured":"Mungthin M, Khositnithikul R, Sitthichot N, Suwandittakul N, Wattanaveeradej V, Ward SA, et al. Association between the pfmdr1 gene and in vitro artemether and lumefantrine sensitivity in Thai isolates of Plasmodium falciparum. Am J Trop Med Hyg. 2010;83:1005\u20139.","journal-title":"Am J Trop Med Hyg"},{"key":"1379_CR31","doi-asserted-by":"crossref","first-page":"5069","DOI":"10.1128\/AAC.00638-09","volume":"53","author":"L Mwai","year":"2009","unstructured":"Mwai L, Kiara SM, Abdirahman A, Pole L, Rippert A, Diriye A, et al. In vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan Plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1. Antimicrob Agents Chemother. 2009;53:5069\u201373.","journal-title":"Antimicrob Agents Chemother"},{"key":"1379_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.01790-12","volume":"58","author":"S Dahlstr\u00f6m","year":"2014","unstructured":"Dahlstr\u00f6m S, Aubouy A, Ma\u00efga-Ascofar\u00e9 O, Faucher JF, Wakpo A, Ezinm\u00e8gnon S, et al. Plasmodium falciparum polymorphism associated with ex vivo drug susceptibility and clinical effectiveness of artemisinin-based combination therapies in Benin. Antimicrob Agents Chemother. 2014;58:1\u201310.","journal-title":"Antimicrob Agents Chemother"},{"issue":"191","key":"1379_CR33","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1086\/427997","volume":"2005","author":"C Sisowath","year":"2005","unstructured":"Sisowath C, Stromberg J, Martensson A, Msellem M, Obondo C, Bj\u00f6rkman A, Gil JP. In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem). J Infect Dis. 2005;2005(191):1014\u20137.","journal-title":"J Infect Dis"},{"key":"1379_CR34","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1365-3156.2007.01843.x","volume":"12","author":"C Sisowath","year":"2007","unstructured":"Sisowath C, Ferreira PE, Bustamante LY, Dahlstr\u00f6m S, Martensson A, Bjorkman A, et al. The role of pfmdr1 in Plasmodium falciparum tolerance to artemether\u2013lumefantrine in Africa. Trop Med Int Health. 2007;12:736\u201342.","journal-title":"Trop Med Int Health"},{"key":"1379_CR35","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1086\/444460","volume":"41","author":"A Martensson","year":"2005","unstructured":"Martensson A, Stromberg J, Sosowath C, Msellem MI, Gil JP, Montgomery SM, et al. Efficacy of artesunate plus amodiaquine versus that of artemether\u2013lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania. Clin Infect Dis. 2005;41:1079\u201386.","journal-title":"Clin Infect Dis"},{"key":"1379_CR36","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1128\/AAC.50.5.1893-1895.2006","volume":"50","author":"C Dokomajilar","year":"2006","unstructured":"Dokomajilar C, Nsobya SL, Greenhouse B, Rosenthal PJ, Dorsey G. Selection of Plasmodium falciparum pfmdr1 alleles following therapy with artemether\u2013lumefantrine in an area of Uganda where malaria is highly endemic. Antimicrob Agents Chemother. 2006;50:1893\u20135.","journal-title":"Antimicrob Agents Chemother"},{"key":"1379_CR37","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0140-6736(04)16767-6","volume":"364","author":"RN Price","year":"2004","unstructured":"Price RN, Uhlemann AC, Brockman A, McGready R, Ashley E, Phaipun L, et al. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet. 2004;364:438\u201347.","journal-title":"Lancet"},{"key":"1379_CR38","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.meegid.2005.09.001","volume":"6","author":"G Holmgren","year":"2006","unstructured":"Holmgren G, Gil JP, Ferreira PM, Veiga MI, Obonyo CO, Bjorkman A. Amodiaquine resistant Plasmodium falciparum malaria in vivo is associated with selection of pfcrt 76T and pfmdr1 86Y. Infect Gen Evol. 2006;6:309\u201314.","journal-title":"Infect Gen Evol"},{"key":"1379_CR39","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1128\/AAC.00012-07","volume":"51","author":"SL Nsobya","year":"2007","unstructured":"Nsobya SL, Dokomajilar C, Joloba M, Dorsey G, Rosenthal PJ. Resistance-mediating Plasmodium falciparum pfcrt and pfmdr1 alleles after treatment with artesunate\u2013amodiaquine in Uganda. Antimicrob Agents Chemother. 2007;51:3023\u20135.","journal-title":"Antimicrob Agents Chemother"},{"key":"1379_CR40","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1475-2875-8-89","volume":"8","author":"S Picot","year":"2009","unstructured":"Picot S, Olliaro P, de Monbrison F, Bienvenu AL, Price RN, Ringwald P. A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria. Malar J. 2009;8:89.","journal-title":"Malar J"},{"key":"1379_CR41","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S1471-4922(01)02085-2","volume":"17","author":"CH Sibley","year":"2001","unstructured":"Sibley CH, Hyde JE, Sims PF, Plowe CV, Kublin JG, Mberu EK, et al. Pyrimethamine\u2013sulfadoxine resistance in Plasmodium falciparum: what next? Trends Parasitol. 2001;17:582\u20138.","journal-title":"Trends Parasitol"},{"key":"1379_CR42","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/j.1365-3156.2005.01506.x","volume":"10","author":"D Ndiaye","year":"2005","unstructured":"Ndiaye D, Dailly JP, Sarr O, Ndir O, Gaye O, Mboup S, et al. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase genes in Senegal. Trop Med Int Health. 2005;10:1176\u20139.","journal-title":"Trop Med Int Health"},{"key":"1379_CR43","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijpddr.2013.07.001","volume":"3","author":"D Ndiaye","year":"2013","unstructured":"Ndiaye D, Dieye B, van Tyne D, Daniels R, Bei AK, Mbaye A, et al. Polymorphism in dhfr\/dhps genes, parasite density and ex vivo response to pyrimethamine in Plasmodium falciparum malaria parasites in Thies, Senegal. Int J Parasitol Drugs Drug Resist. 2013;3:135\u201342.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"1379_CR44","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00436-010-2236-9","volume":"109","author":"B Faye","year":"2011","unstructured":"Faye B, Ndiaye M, Ndiaye JL, Annie A, Tine RC, Coll\u00e9 Lo A, et al. Prevalence of molecular markers of Plasmodium falciparum resistance to sulfadoxine\u2013pyrimethamine during the intermittent preventive treatment in infants coupled with expanded program immunization in Senegal. Parasitol Res. 2011;109:133\u20138.","journal-title":"Parasitol Res"},{"key":"1379_CR45","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/1475-2875-12-137","volume":"12","author":"AC Lo","year":"2013","unstructured":"Lo AC, Faye B, Ba EH, Cisse B, Tine R, Abiola A, et al. Prevalence of molecular markers of drug resistance in an area of seasonal malaria chemoprevention in children in Senegal. Malar J. 2013;12:137.","journal-title":"Malar J"},{"key":"1379_CR46","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1128\/AAC.01346-15","volume":"60","author":"A Boussaroque","year":"2016","unstructured":"Boussaroque A, Fall B, Madamet M, Camara C, Benoit N, Fall M, et al. Emergence of mutations in the K13 propeller domain gene of Plasmodium falciparum isolates from Dakar, in 2013\u20132014. Antimicrob Agents Chemother. 2016;60:624\u20137.","journal-title":"Antimicrob Agents Chemother."},{"key":"1379_CR47","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature12876","volume":"505","author":"F Ariey","year":"2014","unstructured":"Ariey F, Witkowsky B, Amaratunga C, Beghain J, Langlois AC, Khim N, et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature. 2014;505:50\u20135.","journal-title":"Nature"},{"key":"1379_CR48","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1314981","volume":"371","author":"EA Ashley","year":"2015","unstructured":"Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2015;371:411\u201323.","journal-title":"N Engl J Med"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-016-1379-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T16:52:26Z","timestamp":1568134346000},"score":1,"resource":{"primary":{"URL":"http:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-016-1379-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,7]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1379"],"URL":"https:\/\/doi.org\/10.1186\/s12936-016-1379-2","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,7]]},"article-number":"347"}}